Mydriasis is the dilation of the pupil, which may be due to a non-physiological cause such as disease, trauma, drugs usage, or physiological pupillary response.
Mydriasis Epidemiology
The Mydriasis epidemiology division provides insights about the historical and current patient pool along with the forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Mydriasis Epidemiology Segmentation in 7MM from 2017 to 2030
- Total Prevalent cases of Mydriasis
- Gender-Specific cases of Mydriasis
- Age-Specific cases of Mydriasis
- Total Diagnosed and Treatable cases of Mydriasis
Mydriasis Epidemiology Insights
- The diagnosed prevalent population of Mydriasis in the United States in 2017 was 3,580,350
- Gender-Specific cases in the United States in 2017
- 1,432,140 cases – Males
- 2,148,210 cases – Females
- The cataract surgeries in the United States in 2017
2,100,000 – Females
1,400,000 – Males - Cataract Surgeries were performed in the age-specific cases (70–79) in the United States in 2017 was 1,390,000
- Cataract Surgeries were performed in 2017
- France – 870,000
- Germany – 870,000
- Spain -350,000
- Japan – 1,290,000
Scope of the Report
• The Mydriasis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns.
• The Mydriasis Epidemiology Report and Model provide an overview of the risk factors and global trends of Mydriasis in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
• The report provides insight about the historical and forecasted patient pool of Mydriasis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
• The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of Mydriasis.
• The report provides the segmentation of the Mydriasis epidemiology by Prevalent Cases of Mydriasis in 7MM.
• The report provides the segmentation of the Mydriasis epidemiology by Gender-specific Prevalent Cases of Mydriasis in 7MM.
• The report provides the segmentation of the Mydriasis epidemiology by Age-specific Prevalent Cases of Mydriasis in 7MM.
Request for sample pages
Table of contents
1. Key Insights
2. Organizations
3. Executive summary
4. Epidemiology Methodology
5. Mydriasis: Market Overview at a Glance
5.1. Total Patient Share (%) Distribution of Mydriasis in 2017
5.2. Total Patient Share (%) Distribution of Mydriasis in 2030
6. Overview
6.1. Introduction
6.2. Causes
6.3. Physiology
6.4. Utility in Diagnostics and Therapy
7. Epidemiology and Patient Population
7.1. Key Findings
7.2. Total cases of Mydriasis in 7MM
7.3. United States
7.3.1. Assumptions and Rationale
7.3.2. Total Prevalent cases of Mydriasis in the United States
7.3.3. Gender-specific cases of Mydriasis in the United States
7.3.4. Age-specific cases of Mydriasis in the United States
7.4. EU5 Countries
7.4.1. Assumptions and Rationale
7.5. Germany
7.5.1. Total Prevalent cases of Mydriasis in Germany
7.5.2. Gender-specific cases of Mydriasis in Germany
7.5.3. Age-specific cases of Mydriasis in Germany
7.6. France
7.6.1. Total Prevalent cases of Mydriasis in France
7.6.2. Gender-specific cases of Mydriasis in France
7.6.3. Age-specific cases of Mydriasis France
7.7. Italy
7.7.1. Total Prevalent cases of Mydriasis in Italy
7.7.2. Gender-specific cases of Mydriasis in Italy
7.7.3. Age-specific cases of Mydriasis in Italy
7.8. Spain
7.8.1. Total Prevalent cases of Mydriasis in Spain
7.8.2. Gender-specific cases of Mydriasis in Spain
7.8.3. Age-specific cases of Mydriasis Spain
7.9. UK
7.9.1. Total Prevalent cases of Mydriasis in the United Kingdom
7.9.2. Gender-specific cases of Mydriasis in the United Kingdom
7.9.3. Age-specific cases of Mydriasis in the United Kingdom
7.10. Japan
7.10.1. Assumptions and Rationale
7.10.2. Total Prevalent cases of Mydriasis in Japan
7.10.3. Gender-specific cases of Mydriasis in Japan
7.10.4. Age-specific cases of Mydriasis in Japan
8. KOL Views
9. Bibliography
10. Appendix
10.1.Report Methodology
11. DelveInsight Capabilities
12. Disclaimer
13. About DelveInsight
Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: +919650213330
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/